Note: This is an archived Handbook entry from 2010.
|Dates & Locations:|| |
This subject has the following teaching availabilities in 2010:Year Long, Parkville - Taught online/distance.
Year Long, Parkville - Taught on campus.
Timetable can be viewed here. For information about these dates, click here.
|Time Commitment:||Contact Hours: 30 contact hours (3 hours per week) |
Total Time Commitment: Not available
|Recommended Background Knowledge:||.|
|Non Allowed Subjects:||.|
|Core Participation Requirements:||For the purposes of considering request for Reasonable Adjustments under the Disability Standards for Education (Cwth 2005), and Students Experiencing Academic Disadvantage Policy, academic requirements for this subject are articulated in the Subject Description, Subject Objectives, Generic Skills and Assessment Requirements of this entry. The University is dedicated to provide support to those with special requirements. Further details on the disability support scheme can be found at the Disability Liaison Unit website : http://www.services.unimelb.edu.au/disability/|
ContactProfessor Albert Frauman, email@example.com
|Subject Overview:||To provide an understanding of the clinical pharmacology and clinical utility of drugs in various system disorders, cardiac disorders, including cardiac failure, hypertension, arrhythmia, hyperlipidaemia, respiratory disorders, haematological disorders, neurological disorders, infective diseases, oncology and haematology. In addition, principles of epidemiology, clinical trial design and notification (including compassionate use procedures, post-marketing surveillance and safety assessment), animal and human trial designs and institutional ethics committees are covered.|
|Breadth Options:|| |
This subject is not available as a breadth subject.
|Fees Information:||Subject EFTSL, Level, Discipline & Census Date|
Graduate Diploma in Drug Evaluation and Pharmaceutical Sciences |
Download PDF version.